Burden of salmonellosis, campylobacteriosis and listeriosis : a time series analysis, Belgium, 2012 to 2020 by Maertens de Noordhout, Charline et al.
1www.eurosurveillance.org
Research article
Burden of salmonellosis, campylobacteriosis and 
listeriosis: a time series analysis, Belgium, 2012 to 2020
C Maertens de Noordhout ¹ , B Devleesschauwer ² , JA Haagsma ³ , AH Havelaar 4 5 , S Bertrand ² , O Vandenberg ⁶ , S Quoilin ² , PT 
Brandt ⁷ , N Speybroeck ¹ 
1. Institute of Health and Society (IRSS), Université catholique de Louvain, Brussels, Belgium
2. Department of Public Health and Surveillance, Scientific Institute of Public Health (WIV-ISP), Brussels, Belgium
3. Department of Public Health, Erasmus MC, Rotterdam, the Netherlands
4. University of Florida, Gainesville, Florida, United States
5. Utrecht University, Utrecht, the Netherlands
6. Université libre de Bruxelles, Brussels, Belgium
7. University of Texas, Dallas, Richardson, Texas, United States
Correspondence: Charline Maertens de Noordhout (charline.maertens@uclouvain.be)
Citation style for this article: 
Maertens de Noordhout C, Devleesschauwer B, Haagsma JA, Havelaar AH, Bertrand S, Vandenberg O, Quoilin S, Brandt PT, Speybroeck N. Burden of salmonellosis, 
campylobacteriosis and listeriosis: a time series analysis, Belgium, 2012 to 2020. Euro Surveill. 2017;22(38):pii=30615. DOI: http://dx.doi.org/10.2807/1560-7917.
ES.2017.22.38.30615 
Article submitted on 10 June 2016 / accepted on 09 May 2017 / published on 21 September 2017
Salmonellosis, campylobacteriosis and listeriosis are 
food-borne diseases. We estimated and forecasted the 
number of cases of these three diseases in Belgium 
from 2012 to 2020, and calculated the corresponding 
number of disability-adjusted life years (DALYs). The 
salmonellosis time series was fitted with a Bai and 
Perron two-breakpoint model, while a dynamic linear 
model was used for campylobacteriosis and a Poisson 
autoregressive model for listeriosis. The average 
monthly number of cases of salmonellosis was 264 
(standard deviation (SD): 86) in 2012 and predicted to 
be 212 (SD: 87) in 2020; campylobacteriosis case num-
bers were 633 (SD: 81) and 1,081 (SD: 311); listeriosis 
case numbers were 5 (SD: 2) in 2012 and 6 (SD: 3) in 
2014. After applying correction factors, the estimated 
DALYs for salmonellosis were 102 (95% uncertainty 
interval (UI): 8–376) in 2012 and predicted to be 82 
(95% UI: 6–310) in 2020; campylobacteriosis DALYs 
were 1,019 (95% UI: 137–3,181) and 1,736 (95% UI: 
178–5,874); listeriosis DALYs were 208 (95% UI: 192–
226) in 2012 and 252 (95% UI: 200–307) in 2014. New 
actions are needed to reduce the risk of food-borne 
infection with Campylobacter spp. because campy-
lobacteriosis incidence may almost double through 
2020.
Introduction
Salmonellosis in humans is caused by non-typhoidal 
Salmonella enterica, bacteria originating in animal res-
ervoirs that can spread to humans through contami-
nated foods, such as eggs as well as raw meat from 
pigs and chickens, and through non-food pathways, 
such as direct contact with infected animals or humans 
[1,2]. The most common symptoms of human salmonel-
losis include fever, diarrhoea and abdominal cramps, 
but if bacteria invade the bloodstream, they can cause 
septicaemia and even death. Irritable bowel syndrome 
(IBS), inflammatory bowel disease (IBD) and reactive 
arthritis are possible consequences of salmonellosis 
[2]. For 2010, the World Health Organization (WHO) 
estimated that non-typhoidal salmonellosis caused 
three disability-adjusted life years (DALYs) per 100,000 
population (95% uncertainty interval (UI): 2–5) in the 
WHO European Region [3,4].
Campylobacteriosis is mainly caused in humans by 
the Gram-negative bacteria Campylobacter jejuni and 
C. coli. Transmission to humans is most often associ-
ated with the handling and consumption of poultry 
meat, but can also occur through other pathways, such 
as handling and consumption of contaminated water 
[5]. The main symptom of campylobacteriosis is mild 
or self-limiting gastroenteritis, but infection can also 
lead to immune-mediated diseases such as Guillain–
Barré syndrome and reactive arthritis [1,4,6,7]. It was 
estimated that in 2010, Campylobacter spp. caused the 
highest number of laboratory-confirmed food-borne 
bacterial infections worldwide (96 million, 95% UI: 
51–177) [3]. In 2010, food-borne campylobacteriosis 
was estimated to cause 9 DALYs per 100,000 popula-
tion (95% UI: 6–13) in the WHO European Region [3].
Listeriosis is caused by the Gram-positive bacterium 
Listeria monocytogenes that, in contrast to many other 
food-borne pathogens, can grow at refrigeration tem-
peratures [8]. This ability to persist and multiply in the 
food storage environment makes L. monocytogenes 
particularly difficult to control [8]. L. monocytogenes 
infections in healthy individuals may cause febrile 
gastroenteritis that is usually mild and self-limiting, 
but in patients with impaired immunity, it can lead to 
severe disease including septicaemia, meningitis or 
2 www.eurosurveillance.org
encephalitis with sequelae or death [9]. Infection dur-
ing pregnancy may result in spontaneous abortions 
or stillbirths [10]. In 2010, listeriosis was estimated to 
cause two DALYs per 100,000 population (95% UI: 1–2) 
in the WHO European Region [3,11].
The DALY metric quantifies the burden of a disease 
as the number of healthy years of life lost to morbid-
ity and mortality, and is an internationally recognised 
summary measure of population health. It facilitates 
comparing the relative impact of diseases and risk fac-
tors over time [12,13]. DALYs have been used to esti-
mate the burden of non-communicable diseases or 
injury in Belgium [14-16], but they have not been used 
to estimate the burden of communicable diseases 
even though its applicability to such has been demon-
strated for other European countries [17-19]. To date, 
neither the future global nor future Belgian burden 
of food-borne diseases has been predicted despite a 
changing, ageing population, and life expectancy pos-
sibly influencing the burden of the bacterial food-borne 
diseases in the coming years. The use of time series 
analyses, which is mainly used in economics, may be 
relevant for studying trends and future trends of food-
borne diseases.
This study tries to address the aforementioned gaps 
by providing estimates of the current and future num-
bers of salmonellosis, campylobacteriosis and listeri-
osis cases, and the resulting DALYs, in Belgium from 
Figure 1
Seasonal-trend-loess (STL) decomposition of monthly Belgian campylobacteriosis data, Belgium, 1993–2013
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2012 to 2020 using time series analyses. This study 
will generate valuable information for decision makers 
and researchers, provide an explanation of the devel-
opment of suitable time series models for forecasting 
cases of food-borne infections and may be a starting 
point for other burden of food-borne diseases studies 
in Belgium.
Methods
Data
The Belgian Scientific Institute of Public Health (WIV-
ISP) collects data on laboratory-confirmed salmo-
nellosis, campylobacteriosis and listeriosis cases in 
Belgium. The National Reference Centre for Salmonella 
spp. and Listeria spp. of the WIV-ISP receives strains 
from Belgian laboratories in order to type them or 
define their antimicrobial resistance profile [20]. 
Positive results of stool cultures for Campylobacter 
spp. are collected by laboratories participating in the 
Belgian Sentinel Network of Laboratories (SNL) that 
was created in 1983 to monitor trends in infectious dis-
eases. About 60% of Belgian laboratories participate 
in this sentinel system [21]. The number of cases per 
month were available from January 2001 to December 
2012 for salmonellosis, from January 1993 to December 
2013 for campylobacteriosis and from January 2011 to 
December 2013 for listeriosis. We included all reported 
cases of campylobacteriosis and salmonellosis in 
Belgium without distinguishing the origin of the infec-
tion, i.e. not all Salmonella and Campylobacter infec-
tions will have been caused by the consumption of 
contaminated food. Hald et al. estimate that for the 
EUR-A subregion, which includes Belgium, the propor-
tion of salmonellosis and campylobacteriosis cases 
attributable to food was 76% (95% UI: 47–94%) and 
76% (95% UI: 44–93) in 2010, respectively [22].
Salmonellosis model development
The salmonellosis time series consisted of the monthly 
number of cases from January 2001 to December 2012. 
Visual inspection of the salmonellosis time series 
showed that there was a downward trend after 2006 
and strong seasonality. Because both the Shapiro 
and Jarque-Bera tests rejected the normality of the 
salmonellosis time series distribution (p < 0.001), and 
because autocorrelation and partial autocorrelation 
plots (supplementary material [23]) indicated that the 
Figure 2
Outcome trees used for disability-adjusted life year calculations of campylobacteriosis, salmonellosis and listeriosis 
(acquired and perinatal), Belgium
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Outcome trees were designed according to data availability and those suggested by the European Centre for Disease Prevention and Control 
(ECDC) [35].
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data were highly autocorrelated and seasonal, we 
needed a nonlinear, non-Gaussian time series model.
Collard et al. [24] previously reported a dramatic 
drop in salmonellosis cases in Belgium after 2005. 
They noted that in 2003, Belgium adopted changes 
in the breeder-flock poultry monitoring and control 
programme, with a possible influence on Salmonella 
transmission and control. Furthermore, since 2003, a 
poultry vaccination programme has been in place [24]. 
However, the effects of these policy changes could not 
be dated exactly, meaning that the time series was 
not easy to segment into forecastable sub-series and 
that the data exhibited possible non-stationarity or 
unstable behaviour [25], therefore requiring the need 
for a change-point model. We selected the Bai and 
Perron [26,27] change-point model for autoregressive 
time series models allowing for structural changes 
in the parameters. The time series’ partial autocor-
relation function (PACF) and autocorrelation function 
(ACF) related to the Bai and Perron model resulted in 
stationarity (supplementary material [23]), suggesting 
that the change-point model could explain the intense 
changes in the dynamics, levels and trends in the data. 
The model identified the number and location (in time) 
of the breakpoints. Since adding more breakpoints will 
always result in lower errors in a regression context, a 
Bayesian information criterion (BIC) was used for final 
model selection to ensure the selection of a model with 
an optimal set of breakpoints [26]. The choice of the 
number and location of the lagged values used in the 
model was made such that the residuals of the final 
regression were white noise or serially uncorrelated.
The final model with serially uncorrelated residuals for 
the series St had the form:
where the sub-samples for the m breakpoints are 
defined by the indices at time t,
This regression had m sets of regression coefficients 
for the m+1 subsets of the data. The lagged St terms 
captured the first and second order and seasonal 
autoregressive effects. The c and ϕ1j, ϕ2j, ϕ12j are the 
intercept and autoregressive terms for the effects of the 
lagged values at times t−1, t−2, and t−12. These autore-
gressive terms captured the lagged effects of the previ-
ous 2 months and the seasonal correlation across the 
same month the previous year. The normalised trend 
term βjt was allowed to vary across the regimes allow-
ing for determination of whether the trend increased or 
decreased over the data.
Figure 3
Monthly observed and forecasted salmonellosis cases, Belgium, 2001–2020
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St = c + ϕ1jSt−1 + ϕ2jSt−2 + ϕ12jSt−12 +      +ϵ t
β jt
T
Formula 1
t = t
j−1
+1, …, tj, j=1, …, m+1
Formula 2
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Campylobacteriosis model development
The campylobacteriosis time series consisted of the 
monthly number of cases from December 1993 to 
December 2013. Visual inspection of the campylobac-
teriosis time series showed a time-varying behaviour 
and a strong seasonality. As for salmonellosis, we 
first investigated the distributional properties of the 
data. The PACF and ACF for the campylobacteriosis 
time series indicated strong seasonality, as well as 
low order autocorrelation since there were significant 
spikes at the low order lags (1–4 in the PACF plot) (sup-
plementary material [23]). A time-varying behaviour 
was indicated by shifts in the trend over time (sup-
plementary material [23]), suggesting that a dynamic 
linear model (DLM) was appropriate. While the autore-
gressive integrated moving average (ARIMA) models 
may be appropriate for fitting these data, such mod-
els would forecast poorly since they assume constant 
parameters. Further, for the data at hand, ARIMA mod-
els resulted in coefficients indicating borderline non-
stationarity. The trend in these data had a stochastic 
drift and varied locally, increasing at an earlier stage in 
the sample and at the end, but staying relatively con-
stant in between. The DLM dealt with potential issues, 
estimated the time-varying trend and recognised that 
there were parameter stability issues around the sea-
sonal component of the data. The DLM was made up 
of separate components for the drift, trend and cyclical 
components of the time series. With a DLM, these sepa-
rate components were filtered out of the data resulting 
in a forecasting model with both fixed and time-varying 
parameters. As Figure 1 shows, the seasonal compo-
nent of the data was not constant over time, and the 
seasonal variation has been lower since 2007. Second, 
there is a strong upward trend in the data as the trend 
ranges from 4,000 to nearly 8,000 cases per year and 
fluctuates over time, further supporting the choice of a 
time-varying parameter model like a DLM.
The DLM contains three components: a stochastic lin-
ear trend, a time-varying set of deterministic dummy 
variables for the seasonal component and a first order 
autoregression. The linear trend allowed for captur-
ing the changing trend seen in Figure 1. The seasonal 
terms captured the time-varying seasonality in Figure 
1. Finally, the autoregression captured the serial cor-
relation reported in the supplementary material [23]. 
The resulting model was fitted via maximum likelihood 
methods.
Listeriosis model development
The listeriosis time series counted monthly cases 
from January 2011 to December 2013. Visual inspec-
tion of the listeriosis time series showed a stochastic 
distribution of the cases. This was a relatively short 
time series so a comparison of both a dynamic or time 
series model and a static prediction were in order. The 
short available data time span of 36 months did not 
enable us to obtain reliable estimates of seasonal or 
other dynamic patterns, and only allowed us to reason-
ably forecast for one year. While it would appear that 
there might be some seasonality, the testing for serial 
correlation in the series via ACFs (supplementary mate-
rial [23]) showed no significant serial correlation in the 
time series.
The lack of significance for serial correlation via ACF 
tests did not mean that there was no serial correla-
tion in the count series. To better investigate the serial 
correlation aspects, a series of Poisson autoregres-
sive (PAR(p)) models were fitted to the data. The main 
choice in employing the model is the order of the lag, 
the integer value of p. In this analysis, values of p from 
one to four were tested. The best fitting model was 
chosen based on the statistical significance of the esti-
mated autoregressive coefficients and was a PAR(2) 
model. Predictions from this model were made by sim-
ulation using direct forecasting via the mean prediction 
function from Brandt and Williams [28].
A simulation of 1,000 forecast paths was employed for 
the three developed models, one for each disease, to 
generate mean forecasts and to compute a confidence 
region for them.
DALY calculations
The burden of salmonellosis, campylobacteriosis and 
listeriosis was evaluated in terms of DALYs. DALYs were 
calculated according to the standard formulas [29], 
without age weighting and time discounting. Standard 
expected years of life lost were based on the Global 
Burden of Disease (GBD) 2010 model life table [30], 
while Belgian life tables were used for estimating life-
long durations of sequelae [31]. We calculated DALYs in 
2012 based on observed number of cases, and DALYs 
in 2014 and 2020 based on the number of cases esti-
mated by the three models developed above. The inci-
dence calculations were based on a Belgian population 
of 11,161,642 inhabitants in 2012, 11,226,322 inhabit-
ants in 2014 and a prediction of 11,364,047 inhabitants 
Figure 4
Monthly confirmed salmonellosis cases by species, 
Belgium, 2001–2012
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Figure 5
Fitted dynamic linear model (DLM) and decomposition for the Belgian campylobacteriosis series, Belgium, 1993–2013
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Figure 6
Monthly observed and forecasted campylobacteriosis cases, Belgium, 1993–2020
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in 2020 based on United Nations estimations assum-
ing a medium fertility rate [32]. We did not correct for 
comorbidity, but we did correct for under-reporting of 
salmonellosis and campylobacteriosis cases in Belgium 
using the under-reporting factors (URF) developed for 
Belgium, 3.5 (95% UI: 0.3–11.3) for salmonellosis and 
10.5 (95% UI: 3.2–26.5) for campylobacteriosis [33]. 
We did not correct the listeriosis time series for under-
reporting as the severity of the cases was assumed to 
imply perfect reporting.
The DALY calculations were conducted in R version 
3.1.1 using the FERG package [34]. Uncertainty was 
propagated using 1,000 Monte Carlo simulations and 
results were presented as the mean and 95% UI of the 
resulting uncertainty distributions.
Outcome trees
To estimate the full burden caused by a pathogen, 
all health outcomes of the infection and their possi-
ble transitions were considered by using an outcome 
tree. We based our outcome trees and transition prob-
abilities on those suggested by the European Centre 
for Disease Prevention and Control (ECDC) [35] (Figure 
2) for salmonellosis, campylobacteriosis and listeri-
osis because these probabilities were not available 
specifically for Belgian population. The proportion of 
perinatal listeriosis cases, defined as materno-fetal 
cases including pregnancy-associated cases and cases 
in newborns during the first month of life, was taken 
from Maertens de Noordhout et al. [11]. A materno-fetal 
infection with L. monocytogenes was counted as one 
case in the time series. We adopted durations and dis-
ability weights (DWs), the latter based on a scale from 
zero to one where 0 is a health state equivalent to full 
health and 1 is a health state is equivalent to death, as 
proposed by ECDC [35]. For salmonellosis and campy-
lobacteriosis, we used a DW of 0.073 (95% confidence 
interval (CI): 0.061–0.092) for ‘symptomatic uncom-
plicated infections’, 0.149 (95% CI: 0.120–0.182) for 
‘symptomatic complicated infections (general practi-
tioner (GP))’, 0.239 (95% CI: 0.202–0.285) for ‘symp-
tomatic complicated infections (hospital)’ [36], 0.344 
(95% CI: 0.300–0.390) for ‘reactive arthritis’ [37], 0.053 
(95% CI: 0.042–0.064) for ‘Guillain–Barré syndrome, 
mild’, 0.520 (95% CI: 0.465–0.581) for ‘Guillain–Barré 
syndrome, severe’ and 0.421 (95% CI: 0.377–0.477) 
for ‘permanent disability following Guillain–Barré syn-
drome’ [38]. For listeriosis we used a DW of 0.149 (95% 
CI: 0.120–0.182) for ‘symptomatic uncomplicated infec-
tion’, 0.655 (95% CI: 0.579–0.727) for ‘symptomatic 
complicated infection’ and a 95% CI of 0.011–0.421 for 
‘permanent disability due to meningitis’ [39].
Results
Salmonellosis
Model performance and incidence forecast
Fitting up to a five breakpoint model (m=5), the opti-
mal BIC was produced for a two breaks model. The esti-
mated breaks were in December 2003 and in November 
Figure 7
Monthly observed and forecasted listeriosis cases, Belgium, 2011–2014
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2005, consistent with the results reported in Collard et 
al. [24]. Table 1 shows the estimated parameters over 
each of the periods.
We observed a strong autoregressive model with sea-
sonality, there were relatively more salmonellosis 
cases from June to August than in other months, and a 
statistically significant positive trend (p < 0.001) during 
the period January 2001 to November 2003.
The dynamics of the second period, from December 
2003 to October 2005, was different compared with the 
dynamics of the first period. The first two autoregres-
sive lags were not significant, but there was a strong 
seasonal component (p < 0.001). The trend became neg-
ative in this period, meaning that the number of cases 
decreased, reflecting the poultry vaccination. During 
this second period, the estimated trend coefficient was 
negative and larger in absolute value than the upward 
trend of the first period.
In the last period from November 2005 to December 
2013, a new equilibrium was reached after the drop 
brought by the changes in vaccination and hygiene pol-
icies. There was no statistically significant intercept or 
trend. Instead, the autoregressive dynamics dominated 
the process. The seasonality became much weaker 
in the third segment of the change-point model and 
explained why the seasonality is much reduced in the 
prediction. It has a much stronger AR(1) and AR(2) com-
ponent that oscillates in the third period and smooths 
out to a long-run equilibrium.
Figure 3 presents the in-sample fit as well as a 96 
month (8 year) forecast of salmonellosis cases through 
to the end of 2020. The time series is well fitted by this 
model (see supplementary material [23]), and the fore-
cast shows a continued decline to the long-run means 
after 2005. Figure 3 also includes simulated one stand-
ard error bands. The 2012 average number of confirmed 
cases per month was 264 (standard deviation (SD): 86) 
and the final equilibrium prediction for 2020 was 212 
cases (SD: 87) per month.
It is of note that in the aggregated data used in 
the analysis, the trend is dominated by S. enterica 
subspecies enterica serovar Enteritidis, with num-
bers decreasing to very low levels, whereas the 
number of cases caused by S. enterica subspecies 
enterica serovar Typhimurium and other S. enter-
ica remains constant across the series (Figure 4). 
DALYs estimates
We estimated that in 2012, salmonellosis caused 102 
DALYs (95% UI: 8–376) or 0.9 DALYs per 100,000 popu-
lation (95% UI: 0.07–3). Based on our forecast model, 
the burden in 2020 would drop to 82 DALYs (95% UI: 
6–310) or 0.7 DALYs per 100,000 population (95% UI: 
0.05–3) (Table 2).
Campylobacteriosis
Model performance and incidence forecast
Figure 5 presents the components of the selected DLM 
model, i.e. trend and seasonal components, being com-
puted recursively with one-step ahead updates using 
the Kalman filter. The top panel of the figure shows the 
data and the filtered and smoothed trend estimates. 
The middle panel gives the time-varying seasonal com-
ponent. The general seasonal pattern is the same, but 
the magnitudes of the seasonality changed over time. 
The last panel shows the residuals. Ljung–Box tests for 
serial correlation failed to reject the null hypothesis of 
serial correlation at multiple lag lengths (lag 1, p = 0.53; 
lag 2, p = 0.55; lag 12, p = 0.31). Since this model had 
white noise residuals and captured the main trend, 
cyclical features and seasonality of the data, it was 
considered the best candidate for forecasting the num-
ber of campylobacteriosis cases in Belgium.
Figure 6 shows the campylobacteriosis forecasts 
through 2020. The upward trend was extrapolated 
from the earlier analysis in Figure 1. The seasonal com-
ponent is seen in the middle panel of Figure 5.
Table 1
Bai and Perron change-point regression estimates for salmonellosis cases, Belgium, 2001–2012
Coefficient Jan 2001– Nov 2003
Standard 
error p value
Dec 2003– 
Oct 2005
Standard 
error p value
Nov 2005– 
Dec 2012
Standard 
error p value
Intercept 144.35 51.94 0.006 626.36 114.70 < 0.001 44.56 50.39 0.378
ϕ1j 1.20 0.10 < 0.001 0.06 0.19 0.759 0.67 0.14 < 0.001
ϕ2j −0.83 0.08 < 0.001 0.05 0.13 0.717 −0.24 0.12 0.049
ϕ12j 0.32 0.08 < 0.001 0.54 0.08 < 0.001 0.36 0.09 < 0.001
βj 2106.07 456.20 < 0.001 −2261.68 375.70 < 0.001 14.54 44.90 0.747
Standard error 73.99
R2 0.99
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The average monthly number of campylobacteriosis 
confirmed cases was 633 (SD: 81) in 2012, with the 
predictions showing an upward trend until 2020 to an 
average of 1,081 (SD: 311) cases per month. The pre-
dictions showed that the campylobacteriosis cases will 
exceed their previous peak of 1,005 cases in August 
2000 in May 2019 (Figure 6).
DALYs estimates
We estimated that campylobacteriosis caused 1,019 
DALYs (95% UI: 137–3,181) or 9 DALYs per 100,000 pop-
ulation (95% UI: 1–29) in 2012, which would increase 
to 1,736 DALYs (95% UI: 178–5,874) or 15 DALYs per 
100,000 population (95% UI: 2–52) in 2020. In 2012, 
63% of the burden was caused by years of life lost 
(Table 2).
Listeriosis
Model performance and incidence forecast
Table 3 shows the estimated coefficients and fit for 
this model. The Wald test for comparison with a static 
Poisson regression had a value of 15.46 with a p value 
less than 0.001, indicating that this model is preferred 
over a standard Poisson regression model. The esti-
mated autoregressive parameters for this model, ρ1 
and ρ2 were negative, meaning there were fewer pre-
dicted listeriosis cases after they were observed.
The mean forecast is 74 cases (SD: 6) in 2014 or six new 
additional cases per month (SD: 2.6) in 2014 (Figure 7).
DALYs estimates
Acquired listeriosis was estimated to have caused 208 
DALYs (95% UI: 192–226) or two DALYs per 100,000 
population (95% UI: 1–2) in 2012 and was predicted to 
cause 252 DALYs (95% UI: 200–307) or two DALYs per 
100,000 population (95% UI: 2–3) in 2014. Perinatal 
listeriosis was estimated to have caused 269 DALYs 
(95% UI: 208–347) or two DALYs per 100,000 popula-
tion (95% UI: 2–3) in 2012 and was predicted to cause 
258 DALYs (95% UI: 204–322) or two DALYs per 100,000 
population (95% UI: 2–3) in 2014. Most of the burden 
is caused by mortality (Table 2).
Discussion
Using time series analysis, we predicted that the bur-
den of salmonellosis will remain stable between 2012 
and 2020, that the burden of listeriosis remained stable 
between 2012 and 2014, but that the burden of campy-
lobacteriosis would increase by a factor of almost two 
by 2020.
Our study also showed that a time series analysis is 
an appropriate methodology to help reveal or clarify 
trends of food-borne illnesses, to forecast future cases 
and to test the impact of interventions on the burden 
of food-borne diseases. Time series models could com-
plement the public health surveillance of food-borne 
diseases [40,41], and could also be used to identify 
irregularities in disease incidence [42,43]. Model appli-
cation can also result in more efficient and cost-effec-
tive control strategies [44].
To our knowledge, this study is the first that used 
and developed segmented regressions, i.e. a Bai and 
Perron model [26], to predict food-borne diseases and 
that predicted salmonellosis cases and DALYs. Others 
have already predicted future DALYs of non-food-borne 
diseases using a demographic dynamics model [45], 
future years lived with disabilities (YLDs) caused by 
Salmonella spp. infection using future temperature 
change prediction [46] and examined seasonal and sec-
ular trends of enteric diseases using spatio-temporal 
analysis [47]. We estimated that salmonellosis caused 
0.9 DALYs per 100,000 population (95% UI: 0.07–3) 
in 2012 in Belgium. This is roughly consistent with 
the estimations of salmonellosis resulting in 3 DALYs 
per 100,000 population (95% UI: 3–5) in 2010 in the 
WHO European Region [3] but less than the estimates 
of 7 DALYs per 100,000 population (95% UI: 5–10) in 
2012 in Denmark [19], 23 DALYs per 100,000 population 
(95% UI: 18–30) in 2007 in Germany [48], and 8 DALYs 
per 100,000 population (95% UI: 4–17) in 2011 in the 
Netherlands [49]. These differences are caused by dif-
ferences in the outcome trees used. Indeed, Irritable 
bowel syndrome (IBS) and Inflammatory bowel disease 
(IBD) are not included in the new outcome trees devel-
oped by ECDC because it concluded that there was not 
enough evidence that salmonellosis resulted in IBS 
and IBD [35].
When we included IBS in our outcome tree, the DALYs 
caused by salmonellosis in Belgium in 2012 increased 
by 107% (supplementary material [23]). The differences 
can be further explained by the fact we adjusted the 
salmonellosis incidence for under-reporting using an 
URF developed by Havelaar et al. [33]. This allowed us 
to compare the burden of salmonellosis with the bur-
den caused by other diseases, such as listeriosis. This 
URF developed by Havelaar et al. for salmonellosis is 
particularly low for Belgium (3.5); by comparison, the 
URFs used in the Danish (7.2) [19], German (8.7) [48] 
and the Dutch (18) [49] studies were higher. Using 
URFs developed for the Netherlands or Germany in 
the scenario analysis, the DALYs caused by salmonel-
losis increased by 653% or 203%, respectively (sup-
plementary material [23]). If we both included IBS as 
a sequela of salmonellosis and used the URF devel-
oped for the Netherlands, we observed an increase 
Table 3
PAR(2) estimates for listeriosis time series, Belgium, 
2011–2013
Coefficient Estimate Standard error Z-score
ρ1 −0.28 0.13 −2.17
ρ2 −0.24 0.15 −1.67
Intercept 1.83 0.06 32.11
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in DALYs of 1456% (supplementary material [23]). The 
case–fatality rate used for DALYs estimations may also 
be a reason for the observed differences in DALYs. For 
instance, Van Lier et al. used an average case–fatality 
rate of 0.10% in the Netherlands [49], which is higher 
than what we used (min 0.05%– max 0.10%). Based 
on the above, it is clear that different methodologies 
used for burden of salmonellosis estimates make com-
parison between countries difficult. There is a need to 
develop more precise URFs for the Belgian population 
because the uncertainty in the URFs of salmonellosis 
remains high, and given the one-to-one relationship 
with the DALY estimate, very influential.
This is the first time that DLM models were used to 
predict food-borne diseases cases and DALYs. Weizent 
et al. also concluded that decomposition models, 
like DLM, are more appropriate models for forecast-
ing campylobacteriosis risk in the United States than 
regression or Box-Jenkins ARIMA models [50]. Nobre 
et al. applied DLM models to malaria and hepatitis A 
data, and concluded that DLM models were adequate 
tools for use in epidemiological surveillance [51]. Using 
a DLM, we estimated that campylobacteriosis caused 
nine DALYs per 100,000 population (95% UI: 1–29) in 
2012. This is equal to the WHO estimates for the WHO 
European Region (9/100,000 population; 95% UI: 6–13) 
and consistent with the estimates for the Netherlands 
in 2011 (2/100,000 population; 95% UI: 8–41) [49] and 
for Denmark in 2012 (28/100,000; 95% UI: 25–33) [19].
We developed a Poisson autoregressive model for lis-
teriosis cases given the short time series. This is the 
first time severe listeriosis burden has been estimated 
in Belgium. We estimated that acquired listeriosis 
caused four DALYs per 100,000 population (95% UI: 
3–4) in both 2012 and 2014. Perinatal listeriosis was 
estimated to cause two DALYs per 100,000 population 
(95% UI: 2–3) in both 2012 and in 2014. These results 
are in line with those of Maertens de Noordhout et al. 
who estimated that listeriosis caused thee DALYs per 
100,000 population (95% UI: 2–3) in 2010 in WHO 
European sub-region A, which includes Belgium [11]. In 
2014, the Belgian Scientific Institute of Public Health 
reported 83 cases of listeriosis which falls within one 
SD from what we predicted for the same year using the 
Poisson model (74 cases, SD: 6.1) [52]. However, our 
listeriosis estimates could have been underestimated 
because we did not correct for under-reporting as the 
severity of the cases was assumed to imply perfect 
reporting. Some listeriosis cases could be uncompli-
cated, especially in healthy people, and thus not be 
reported. Correcting the reported cases of listeriosis 
in Belgium in 2012 by the URF developed by Thomas 
et al. for Canada [53] increased the DALYs caused by 
acquired and perinatal listeriosis by 10% (supplemen-
tary material [23]).
Although this study estimated, for the first time, the 
DALYs linked to salmonellosis and campylobacteriosis 
in 2012 and 2020, and to listeriosis in 2012 and 2014 in 
Belgium, it also had several limitations. First, a major 
limitation of prediction models is that they implicitly 
assume that the environment and context will stay sta-
ble. Changes in knowledge about safe food handling, 
physician testing practices, new public health or ani-
mal health interventions or future outbreaks could all 
violate this assumption, but are impossible to predict 
[54]. Second, we did not include food attribution per-
centages in the burden estimates, which means that 
some campylobacteriosis, salmonellosis and listerio-
sis cases may have been attributed to other sources of 
contamination than the consumption of contaminated 
food. Third, potential clustering of salmonellosis, which 
is more common compared with the other two dis-
eases, was not taken into account in the times series 
analysis. Indeed, in 2012, the European Food Safety 
Authority reported 1,533 Salmonella spp. outbreaks in 
Europe, which is higher than the reported number of 
outbreaks caused by Campylobacter spp. (n = 501) or 
by L. monocytogenes (n = 5) [55]. The presence of clus-
tering will, in general, not influence the estimates, but 
it may have an influence on the UI. Fourth, while we 
used projected life expectancies for sequelae with a 
lifelong duration, we used the same transition proba-
bilities and age distribution of cases for the forecasted 
2020 and estimated 2012 DALY calculations. Of course, 
all parameters would be influenced by many factors, 
including new treatments, improved management of 
food-borne diseases, ageing of the population [45] or 
climate changes [56].
The precision of our time series models could be fur-
ther improved by including relevant covariates; for 
instance, data source, diagnostic method, sex, age, 
prevalence in animals, prevalence in food, or consump-
tion of proton-pump inhibitors that can increase the 
risk of camplylobacteriosis, salmonellosis or listeriosis 
[57,58] could potentially be included in the model. If 
such data are available and included, it would reduce 
the uncertainty of the predictions and produce more 
informed extrapolations. This may in turn increase the 
precision of our estimations, but would require a re-
evaluation of the selected model, especially for listeri-
osis as little data were available for this at the time of 
the study.
Conclusion
Assuming a constant environment, e.g. no change in 
policy and control of salmonellosis, campylobacteri-
osis and listeriosis, the incidence of salmonellosis and 
listeriosis is predicted to remain stable in Belgium, 
while the incidence of campylobacteriosis may almost 
double until 2020. Efforts to control cases of salmonel-
losis and listeriosis in Belgium must be maintained in 
the future whereas new actions are urgently needed 
to understand and reduce the risk of food being con-
taminated with Campylobacter spp. This study is also 
a starting point for other studies that wish to project 
the future burden of disease of other food-borne path-
ogens, and for the Belgian national burden of disease 
study that was launched at the end of 2016.
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